FAQs on paediatric colonoscopy competency pathway
On behalf of Endoscopy Working group.
Guideline for the Implementation of Green Endoscopy in Paediatric Practice
On behalf of Endoscopy Working group. This guideline provides practical, evidence-informed recommendations for implementing green endoscopy within paediatric services supported by BSPGHAN and CAPGHAN.
Transition from neonatal to paediatric care for babies with long term or complex healthcare needs
This framework for practice aims to describe principles for safe, effective and personalised transition of care of babies from neonatal to paediatric services; this includes holistic support of their complex health and care needs and their families’ psychosocial welfare.
LSG|UK Steatotic Liver Guideline 2025-26 Version
This guideline has been designed to aid practitioners in how to proceed when imaging studies identify hepatic steatosis (a bright, hyperechoic liver as compared to the spleen on ultrasound) or raised liver enzymes are detected in an overweight child.
Paediatric Acute Liver Failure Protocol
Acute liver failure (ALF) is a potentially life-threatening condition that necessitates early recognition and optimal management and transfer to a Liver Transplant Centre for further management that might include liver transplantation.
Assessment, monitoring and management of deliberate and accidental paracetamol overdose in Children
Joint Guideline proposed by the Children’s Specialised Liver Services at King’s, Birmingham, and Leeds.
Guidelines for the diagnosis and management of pancreatitis in children
This guideline covers the diagnosis and management of acute and chronic pancreatitis in children and young people (CYP) in the United Kingdom
Acute Liver Failure Guidelines by the The American College of Gastroenterology
Acute liver failure (ALF) is a life-threatening condition that occurs in patients with no preexisting liver disease and is characterized by liver injury (abnormal liver tests), coagulopathy (international normalized ratio [INR] .1.5), and hepatic encephalopathy (HE).
Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children
Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric Committee.
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase.
Proposed Prolonged Jaundice Pathway following national audit 2022-2023
UK Multi-center practice and adaptation of Guidelines from NICE and Liver centre conjugated hyperbilirubinemia pathway.
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis
Transition from neonatal to paediatric care for babies with long term or complex healthcare needs
This framework for practice aims to describe principles for safe, effective and personalised transition of care of babies from neonatal to paediatric services; this includes holistic support of their complex health and care needs and their families’ psychosocial welfare.
Assessment, monitoring and management of deliberate and accidental paracetamol overdose in Children
Joint Guideline proposed by the Children’s Specialised Liver Services at King’s, Birmingham, and Leeds.
BSG Position Paper: Green Endoscopy
Green endoscopy: British Society of Gastroenterology (BSG), Joint Accreditation Group (JAG) and Centre for Sustainable Health (CSH) joint consensus on practical measures for environmental sustainability in endoscopy.
BSPGHAN Motility Working Group position statement: paediatric multichannel intraluminal pH impedance monitoring—indications, methods and interpretation
MII-pH is increasingly used by paediatricians as the diagnostic tool for assessing gastro-oesophageal reflux disease and symptom association. There is wide variation in paediatric practice and a need for standardised practice.
LSG|UK Steatotic Liver Guideline 2025-26 Version
This guideline has been designed to aid practitioners in how to proceed when imaging studies identify hepatic steatosis (a bright, hyperechoic liver as compared to the spleen on ultrasound) or raised liver enzymes are detected in an overweight child.
Paediatric Acute Liver Failure Protocol
Acute liver failure (ALF) is a potentially life-threatening condition that necessitates early recognition and optimal management and transfer to a Liver Transplant Centre for further management that might include liver transplantation.
Acute Liver Failure Guidelines by the The American College of Gastroenterology
Acute liver failure (ALF) is a life-threatening condition that occurs in patients with no preexisting liver disease and is characterized by liver injury (abnormal liver tests), coagulopathy (international normalized ratio [INR] .1.5), and hepatic encephalopathy (HE).
Proposed Prolonged Jaundice Pathway following national audit 2022-2023
UK Multi-center practice and adaptation of Guidelines from NICE and Liver centre conjugated hyperbilirubinemia pathway.
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase.
Early investigation and management of children with acute non-A-E hepatitis, with and without liver failure
This clinical framework is intended to provide a structure for the investigation, transfer and management of children with novel non-A-E acute hepatitis in the context of an emergence of a novel disease. The recommendations within this guidance are based on existing principles of management of acute hepatitis and acute liver failure and on expert consensus opinion in the absence of high quality evidence around this novel condition.
Assessment and Management of Oesophageal Varices in Children
These guidelines were constructed after a joint audit and review of practice at the three specialised centres in June 2016 and reviewed again in 2021. Although evidence based where possible, where not available they represent consensus. A detailed version of this guideline which includes review of evidence, together with reference to adult evidenced based guidelines is available. Section 4: management of acute variceal bleed: is designed for implementation at any hospital to which a child presents and can be used as a stand-alone guideline.
Updated shielding guidance for children with chronic liver disease and those on immunosuppression (autoimmune and liver transplantation
In view of the continuous evidence and increasing knowledge in the COVID-19 pandemic we have undertaken an update on the advice to children and families with chronic liver disease.
NICE and ESPGHAN Guidelines
These guidelines and standards have been published by NICE and ESPGHAN and are available for information. However, please do not hesitate to contact your local Paediatric Hepatology Team to discuss management of a child with any liver disorder.
Investigation of Neonatal Conjugated Jaundice
This guideline aims to advise clinicians on the initial investigations necessary when an infant with conjugated jaundice is identified.
Investigation and treatment of liver disease with acute onset
Defined as EITHER sudden onset of jaundice with evidence of liver aetiology OR incidental discovery of raised transaminases in association with symptoms suggesting acute onset.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Standard versus individualized parenteral nutrition
PN can be provided as a standard, usually commercial, formulation that is designed to meet the nutritional needs of most patients of the same age group with a similar condition.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Lipids
The rate, amount, and type of lipids provided intravenously are important aspects regarding the efficacy and safety in neonates and children.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Iron and trace minerals
Iron is an essential nutrient and iron deficiency results in anemia as well as poor neurodevelopment in children.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Fluid and electrolytes
The aim of the current revision is to update the previous chapter on basis of the scientific evidence published since 2004.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Energy
Energy supply needs to meet the nutritional needs of the patient which include basal metabolic rate, physical activity, growth, diet induced thermogenesis and correction of pre-existing malnutrition.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Carbohydrates
Carbohydrates are the main source of energy in nutrition and usually provide 40-60% of the energy supply in western diets.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Calcium, phosphorus and magnesium
In infants and children growth is the major determinant of mineral requirements.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Amino acids
Recommendations were developed from a standpoint of nutrient adequacy. Depending on age groups, nutrient adequacy was based on intrauterine accretion rate, organ development, factorial estimates of requirements and amino acid interactions. Individual amino acids are discussed.
Recommendations for Nutritional Management of Children with Neurological Impairment (NI)
This guide provides recommendations and a systematic approach for the care of paediatric patients with NI.
Disclaimer: BSPGHAN is not responsible for external content.